The first quarter of 2021 has been one of investor optimism as the vaccine rollout continues ahead of expectations and economic activity begins to accelerate in response. Within the Health IT industry, the already strong investment and M&A trends seen in 2020 have only accelerated. Over the… Read More »Q1 2021 Health IT/Digital Health PC/VE, M&A, IPOs/ SPACs Activity
Peter Meath, J.P. Morgan Commercial Banking’s Co-Head of Healthcare and Life Sciences, applies lessons from 2020’s remarkable second half and shares insights on what to expect in 2021.
Read new developments from Serimmune, Allelica, ForSight Robotics, Owlet Baby Care Inc., and Ascension Ventures.
What You Should Know: Life sciences investment firm OrbiMed announced $3.5 billion in commitments for its latest private investment funds, including $1.5 billion for OrbiMed Private Investments VIII, $800 million for OrbiMed Asia Partners IV, and $1.2 billion for OrbiMed Royalty & Credit Opportunities III.… Read More »Life Sciences Firm OrbiMed Raises $3.5B Across Private Investment Funds
Dexcom launched its first venture fund. The company, which makes continuous glucose monitors, plans to invest in glucose sensing technologies and metabolic monitoring.
INVEST will address six broad themes through a mix of live and pre-recorded sessions: Public Health and Health Equity; Healthcare Delivery; Healthcare Investing & Financing; Empowering Patients; Behavioral Health; and Employer Health.
The MedCity INVEST conference, April 19-23, will include a new session called Ask the Investor. The goal is to provide a forum for healthcare startups to better understand investment strategies for different groups and to ask investors questions.
Walgreens appoints Rosalind (Roz) Brewer as the company’s Chief Executive Officer, effective on March 15, 2021. Brewer will also join the WBA Board of Directors upon assuming the role. She succeeds Stefano Pessina who, as previously announced, will transition to the role of Executive Chairman… Read More »Executive Hires: Walgreens Appoints New CEO, Cityblock Health, Innovaccer, Others
The upcoming MedCity INVEST conference will include a new session, Ask the Investor. The goal is to provide a forum for healthcare startups to better understand investment strategies for different groups and to ask investors questions.
New figures have confirmed that the UK’s biotech sector received a massive boost from the COVID-19 pandemic last year, with investment levels soaring to £2.8 billion ($3.8 billion) from a level of £1.3 billion in 2019. That makes 2020 a new record year for the… Read More »UK biotech investment at record levels amid COVID-19
The tilt was less pronounced in pharma and biotech, which attracted a record level of investment despite the Covid-19 pandemic according to a quarterly report on VC investment activity.
In the face of COVID-19, healthcare witnessed how crises can become the long-awaited push for creativity and innovation that the industry needs. When our healthcare infrastructure’s weaknesses were exposed, telehealth helped to stitch them up, with the number of telehealth claims increasing 8,336% nationally from… Read More »3 Steps to Maintain Telehealth’s Momentum Post-Pandemic
What You Should Know: – Transformation Capital Partners, L.P. (“Transformation Capital”) announced the launches of it’s $500M growth equity fund, Transformation Capital Fund II, L.P. – The new fund will focus on investing between $10 to $30M in commercial-stage digital health companies and technology-enabled service… Read More »Transformation Capital Launches $500M Digital Health Fund
Read about news from healthcare startups including Carrum Health, Aspen RxHealth and more.
Mike McSherry, CEO & Co-founder of Xealth HIT Consultant sat down with Mike McSherry, CEO, and co-founder of Seattle-based digital prescription platform Xealth to discuss digital health lessons learned in 2020 and what we can expect in 2021. As Xealth’s CEO, Mike also works with… Read More »Xealth’s CEO Shares Impact of Digital Health in 2020 and What’s Ahead in 2021
In the last few years, biopharma companies focusing on psychedelic medicines have been springing up like mushrooms – magic or otherwise – and venture capital money is starting to follow. Today sees the launch of the first investment fund in the UK devoted to psychedelic… Read More »VC fund dedicated to psychedelic meds launches in UK
Israel’s specialist venture capital firm, Olive Tree Ventures (OTV) has closed a fund worth $170 million, with plans to expand its portfolio of digital health firms. OTV is the only VC in Israel whose main focus is digital health, specialising in supporting portfolio companies reaching… Read More »Olive Tree Ventures closes $170m dedicated digital health fund
What You Should Know: – OTV (formerly Olive Tree Ventures), Israel’s ‘digital health first’ venture capital firm closes $170 million venture fund to support innovative digital health companies worldwide. – OTV also announced today a new China office and the appointment of Jose Antonio Urrutia Rivas… Read More »Israeli Digital Health VC Firm OTV Closes $170M Venture Fund
Recent Executive Hires: CVS Health New President, Cleveland Clinic/Amwell Joint Venture Leadership, Others
Neela Montgomery, EVP & President at CVS Pharmacy/Retail CVS Health Corporation names Neela Montgomery Executive Vice President and President of CVS Pharmacy/Retail, effective November 30, 2020. Montgomery will oversee the company’s 10,000 pharmacies across the United States. Montgomery, currently a Board Partner at venture capital… Read More »Recent Executive Hires: CVS Health New President, Cleveland Clinic/Amwell Joint Venture Leadership, Others
Trans-Atlantic biotech venture capital firm SR One has completed its spin-out from GlaxoSmithKline and closed its first fund with $500m in its coffers. The VC built itself a considerable reputation after it was founded in 1985 and works with entrepreneurs and scientists to build biotechnology… Read More »VC firm SR One completes GSK spin-out, raising $500m
With so many new entrants hoping to cash in on the success of digital health, it is more important than ever to look for a venture capital firm that has the right relationships and expertise.
A recent report by Rock Health found that Black and female founders of digital health companies received less funding and were more likely to bootstrap their companies than other groups.
The Florida-based hospital plans to launch the fund next year, under the leadership of a newly named vice president of innovation. It will be used to support startups and invest directly in healthcare companies.
What You Should Know: – Israeli-based Peregrine Ventures launches a new $300 million venture capital fund named Peregrine Growth to focus on late-stage life science companies. – Peregrine Growth will invest $20 to $30 million per funding round, with a strong emphasis on companies that… Read More »Peregrine Ventures Launches $300M VC Fund for Late-Stage Life Science Companies
What You Should Know: – Tampa General Hospital announces its plan to launch a new healthcare innovation venture fund to improve the quality and access to care across the Tampa/St. Pete metro area in Q1 2021. – Through TGH InnoVentures, Tampa General will partner with… Read More »Tampa General to Launch Healthcare Innovation Venture Fund in Q1 2021
Ireland-based Fountain Healthcare Partners has raised another €125 million ($131 million) for its third life sciences fund – 25% ahead of its target – and says it will pump most of the money into European therapeutics and medical device companies. The latest cash injection adds… Read More »Kyowa Kirin backs €125m life science fund closed by Fountain Healthcare
Michael A Greely, Co-Founder & General Partner at Flare Capital Partners This will be ugly and sad. Racism has cost this country $16 trillion over the last twenty years according to a recent Citigroup report. Much of this loss ($13 trillion) was attributed to discriminatory lending… Read More »COVID-19 Pandemic Further Exposes Systemic Racism…
The healthcare analytics company said it had raised the extension funding from three new investors and would use it to accelerate development of its real-world evidence technology.
What You Should Know: – CancerIQ raises $5M in Series A funding led by HealthXVentures to accelerate the growth of its genetic cancer risk assessment platform to identify and manage patients at high risk of cancer. – CancerIQ’s technology enables hospitals to use genomics to… Read More »CancerIQ Raises $5M to Expand Genetic Cancer Risk Assessment Platform
In a panel discussion during MedCity INVEST Thursday, investors discussed how the Covid-19 pandemic and social distancing requirements have impacted the way they interact with companies.
Today at MedCity INVEST: Healthcare investment strategies amidst a pandemic and biopharma startups compete
Today’s agenda includes a panel discussion on healthcare investment trends and strategies and the biopharma track of the Pitch Perfect contest, which will include five startups. Register today!
Months into the Covid-19 pandemic, the pace of new investments for startups has picked back up. Five VCs shared what’s changed and how they’re working in the midst of the crisis.
Pamela Aldsworth, head of VC coverage and managing director at J.P. Morgan, discusses deals and dealmaking during the pandemic and how startups can survive, in a special presentation to mark MedCity News’ annual INVEST conference.
What You Should Know: – Digital surgery pioneer Activ Surgical raises $15M in funding led by ARTIS Ventures to accelerate U.S. commercialization and European expansion efforts for its ActiveEdge platform, which enables existing surgical systems, from scopes to robots, to visualize, characterize and track tissue,… Read More »Activ Surgical Raises $15M Advance Autonomous and Collaborative Surgery
What You Should Know: – GYANT raises $13.6M in Series A funding for AI-enabled digital front door solutions to drive meaningful patient-doctor engagement. – The investment will enable GYANT to scale up its product development to meet rapidly increasing market demand and support its exponential… Read More »GYANT Raises $13.6M for AI-Enabled Digital Front Door Solution to Drive Patient-Doctor Engagements
What You Should Know: – Medly Pharmacy raises $100M investment co-led by Volition Capital and Greycroft to propel Medly’s leadership in the $500B+ digital on-demand pharmacy market. – Medly will use the funding to expand its digital on-demand pharmacy platform, enter new markets, and provide… Read More »Medly Pharmacy Lands $100M to Expand Digital On-Demand Pharmacy Platform
Healthcare startups across health IT, diagnostics, biopharma, health services and medical devices will present their technologies to a team of investor judges. Who will rise to the top? Register now to hear these presentations and connect with startups and investors.
A centerpiece of INVEST will be the judges from investment groups who will query participants on their presentations across health IT, diagnostics, health services, medical devices and biopharma.
Here’s your guide to when healthcare startups are pitching at MedCity INVEST. Register now and save.
The INVEST Pitch Perfect contest will be held from July 20-24 and will spotlight healthcare startups across the following tracks: health services, health IT, medical devices, biopharma and diagnostics.
The company is currently running a Phase I study of its lead candidate, the antibody-drug conjugate VLS-101, in patients with lymphomas and leukemias. It has two additional antibody-drug conjugates and a bispecific antibody in preclinical development.
Gain insights from the perspectives of healthcare investors from Maverick Ventures, Cultivation Capital, Advocate Aurora Health and Flare Capital on investment trends in 2020 at the online conference July 20-24. Register now and save.